Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-22

Clinical Trial Update: The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the effects of a bromelain supplement in patients with diabetic foot ulcers; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromelain (bromelain)

Snippet

Sponsor: Dr Azita Hekmatdoost | Conditions: Diabetic Foot Ulcer (DFU) | Phase 3 | Status: NOT_YET_RECRUITING